The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index; 13 of the 29 sources its claims cite were checked for support.
Mitofusin-2 Determines Mitochondrial Network Architecture and Mitochondrial Metabolism
Open accessAbstract
In many cells and specially in muscle, mitochondria form elongated filaments or a branched reticulum. We show that Mfn2 (mitofusin 2), a mitochondrial membrane protein that participates in mitochondrial fusion in mammalian cells, is induced during myogenesis and contributes to the maintenance and operation of the mitochondrial network. Repression of Mfn2 caused morphological and functional fragmentation of the mitochondrial network into independent clusters. Concomitantly, repression of Mfn2 reduced glucose oxidation, mitochondrial membrane potential, cell respiration, and mitochondrial proton leak. We also show that the Mfn2-dependent mechanism of mitochondrial control is disturbed in obesity by reduced Mfn2 expression. In all, our data indicate that Mfn2 expression is crucial in mitochondrial metabolism through the maintenance of the mitochondrial network architecture, and reduced Mfn2 expression may explain some of the metabolic alterations associated with obesity.
Overview
CoChat Summary
TL;DR
Mitofusin-2 (Mfn2), a mitochondrial membrane protein induced during myogenesis, is required to maintain the elongated, intralumenally connected mitochondrial network in muscle cells and to sustain mitochondrial metabolism. Mfn2 expression is reduced in skeletal muscle of obese Zucker rats and obese humans, suggesting its loss contributes to the metabolic alterations of obesity.
Key findings
- Mfn2 mRNA (4.7 kb) is predominant in skeletal muscle and heart, and Mfn2 mRNA and protein are markedly induced during L6E9 myoblast differentiation into myotubes, in parallel with development of an extensive mitochondrial network.
- Antisense repression of Mfn2 in L6E9 myotubes (≈50% reduction in mitochondrial extracts) fragmented the network: 82% of mitochondrial filaments were longer than 5 µm in control cells versus only 22% in antisense cells. Laser microirradiation showed loss of membrane potential spread across the whole network in controls but only a very reduced extension in antisense myotubes.
- Mfn2 repression reduced mitochondrial function: glucose oxidation fell by 30% in myotubes and by 30% (or 70% per the Discussion) in 10T1/2 antisense clones; mitochondrial membrane potential fell by nearly 60%; oxygen consumption fell 30%, with coupled respiration unchanged and proton-leak-linked respiration significantly reduced.
- In obesity, Mfn2 mRNA was 34% lower in Zucker obese rats and 36% lower in obese humans; Mfn2 protein was 39% lower (rats) and 43% lower (humans). Obese rat muscle showed higher mitochondrial density (11.2 ± 0.6 vs 8.2 ± 0.5 organelles/10 µm², p < 0.001), 42% greater total mitochondrial surface area, and 25% lower volume per unit area, consistent with a smaller, fragmented network.
Methods
- Differential screening by PCR-select cDNA subtraction on gastrocnemius muscle from obese (fa/fa) versus lean (fa/+) Zucker rats isolated the 321-bp C31 clone, identified as Mfn2; expression was confirmed by Northern blot, competitive-quantitative RT-PCR, and Western blot with an anti-Mfn2 peptide antibody.
- Human samples: vastus lateralis biopsies from 13 healthy lean volunteers (51 ± 2 years; BMI 23 ± 1 kg/m²; insulin 34 ± 2 pmol/liter) and 9 obese volunteers (46 ± 2 years; BMI 34 ± 1 kg/m²; insulin 62 ± 6 pmol/liter), taken before a 3-h euglycemic hyperinsulinemic clamp (insulin 12 pmol/kg/min); obese subjects showed 50% lower insulin-stimulated glucose disposal (4.9 ± 0.8 vs 10.1 ± 1.1 mg/kg/min).
- Functional work used transient Mfn2 overexpression and antisense knockdown (stable transfection in 10T1/2 fibroblasts; adenoviral antisense in L6E9 myotubes), with confocal immunofluorescence/MitoTracker/JC-1 imaging, laser microirradiation, electron microscopy, [¹⁴C]glucose oxidation, and Clark-electrode respiration measurements; mitochondrial volume/surface area in soleus muscle was quantified by the vertical sections stereological method (4 obese and 4 lean rats, 80 photographs/group at 5,000×).
Limitations
- The paper states that further studies in rodents after recombinant ablation of Mfn2 are required to determine whether it contributes to obesity, and it notes that the mechanism by which Mfn2 supports respiratory chain activity is only postulated (destabilization/reduced activity of certain complexes), not demonstrated.
- The authors note that not all L6E9 myoblasts differentiate in culture (≈30% remain undifferentiated) and that undifferentiated myoblasts are not infected by adenovirus, so the observed reduction in glucose oxidation after antisense infection is a substantial underestimate of the actual inhibition.
- Evident from the text: the human data are cross-sectional and correlational (n = 13 lean, 9 obese), so causality between reduced Mfn2 and obesity-related metabolic alterations is not established; the mitochondrial network/morphology measurements in obesity were made only in Zucker rats, not in human muscle.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
7 Valid · 0 Not valid · 8 Not checked · 69 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We also show that the Mfn2-dependent mechanism of mitochondrial control is disturbed in obesity by reduced Mfn2 expression.”
- Also stated in: § Abstract · plain
“We also show that this regulatory mechanism is disturbed in obesity.”
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Abstract · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Concomitantly, repression of Mfn2 reduced glucose oxidation, mitochondrial membrane potential, cell respiration, and mitochondrial proton leak.”
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Concomitantly, repression of Mfn2 reduced glucose oxidation, mitochondrial membrane potential, cell respiration, and mitochondrial proton leak.”
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“In myoblast cells, a short portion of a mitochondrial filament became de-energized when one of the cluster-composing mitochondria was damaged by laser (Fig. 3,C and D). As a consequence of the loss of mitochondrial membrane potential, mitochondria became unstained by JC-1.”
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Under these conditions, we found that myogenesis caused the induction of Mfn2 protein in L6E9 cells (Fig. 2C).”
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
41 more claims
Create a free account to see all 84 claims and every source verdict.
- Probably not a substantial claim. 15
- It may state two separate claims as one. 27
- The quote only partly states this claim. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Besides its role in mitochondrial fusion, Mfn2 has been described to be involved in the regulation of cell proliferation, oxidative metabolism, autophagy, mitophagy, mitochondrial antiviral signaling, and unfolded protein response (Bach et al, 2003; Chen et al, 2004; Yasukawa et al, 2009; Hailey et al, 2010; Ngoh et al, 2012; Zhao et al, 2012; Chen & Dorn, 2013; Munoz et al, 2013).”
From Mfn2 deficiency links age‐related sarcopenia and impaired autophagy to activation of an adaptive mitophagy pathway (2016) · cites this paper as Bach et al, 2003
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Lipid overloading promotes fast and transient changes in mitochondrial architecture.”
From Mitochondrial response to nutrient availability and its role in metabolic disease (2014) · cites this paper as Bach et al, 2003
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In line with the above observations, obese patients display a largely fragmented mitochondrial network in skeletal muscle (Bach et al, 2003).”
From Mitochondrial response to nutrient availability and its role in metabolic disease (2014) · cites this paper as Bach et al, 2003
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Mfn2 is a nuclear-encoded mitochondrial protein that shows homology with Drosophila or yeast Fzo proteins (26,27) and is highly expressed in skeletal muscle, the heart, and the brain (23).”
From Expression of Mfn2, the Charcot-Marie-Tooth Neuropathy Type 2A Gene, in Human Skeletal Muscle (2005) · cites this paper as [23]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“and mitochondria from obese Zucker rats show higher mitochondrial surface, lower mitochondrial volume, and a lower extent of the mitochondrial network (23).”
From Expression of Mfn2, the Charcot-Marie-Tooth Neuropathy Type 2A Gene, in Human Skeletal Muscle (2005) · cites this paper as [23]
Experimental — accuracy not yet measured
10 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ RESULTS
“Repression of Mfn2 in 10T1/2 cells also reduced glucose oxidation by 307 (Fig. 8C).”
§ DISCUSSION
“cellular repression of Mfn2 in 10T1/2 cells (687 reduction) reduces mitochondrial proton leak and cellular oxygen consumption (307 reduction) and glucose oxidation (707 reduction)”
Citations
Cites
Maffei, M., Halaas, J., Ravussin, E., Pratley, R. E., Lee, G. H., Zhang, Y., Fei, H., Kim, S., Lallone, R., Ranganathan, S., et al. (1995) · Nature Medicine · doi:10.1038/nm1195-1155 · Cited by 3,725
Dysfunction of Mitochondria in Human Skeletal Muscle in Type 2 Diabetes
Kelley, D. E., He, J., Menshikova, E. V., & Ritov, V. B. (2002) · Diabetes · doi:10.2337/diabetes.51.10.2944 · Cited by 2,321
Delettre, C., Lenaers, G., Griffoin, J.-M., Gigarel, N., Lorenzo, C., Belenguer, P., Pelloquin, L., Grosgeorge, J., Turc-Carel, C., Perret, E., et al. (2000) · Nature Genetics · doi:10.1038/79936 · Cited by 1,446
Alexander, C., Votruba, M., Pesch, U. E. A., Thiselton, D. L., Mayer, S., Moore, A., Rodriguez, M., Kellner, U., Leo-Kottler, B., Auburger, G., et al. (2000) · Nature Genetics · doi:10.1038/79944 · Cited by 1,330
Estimation of surface area from vertical sections
Baddeley, A. J., Gundersen, H. J. G., & Cruz‐Orive, L. M. (1986) · Journal of Microscopy · doi:10.1111/j.1365-2818.1986.tb04282.x · Cited by 1,058
Fuel selection in human skeletal muscle in insulin resistance: a reexamination.
Kelley, D. E., & Mandarino, L. J. (2000) · Diabetes · doi:10.2337/diabetes.49.5.677 · Cited by 1,017
Control of mitochondrial morphology by a human mitofusin
Santel, A., & Fuller, M. T. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.5.867 · Cited by 1,012
Leptin receptor missense mutation in the fatty Zucker rat
Phillips, M. S., Liu, Q., Hammond, H. A., Dugan, V., Hey, P. J., Caskey, C. T., & Hess, J. F. (1996) · Nature Genetics · doi:10.1038/ng0596-18 · Cited by 822
Bett, A. J., Haddara, W., Prevec, L., & Graham, F. L. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.19.8802 · Cited by 744
A Human Dynamin-related Protein Controls the Distribution of Mitochondria
Smirnova, E., Shurland, D.-L., Ryazantsev, S. N., & van der Bliek, A. M. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.143.2.351 · Cited by 733
Research works printed but not linked: 3
- Astrup, 1987, Int. J. Obesity, 11, 51
- Kaplan, 1991, Int. J. Obesity, 15, 809
- Buchberger, 1996, Am. J. Physiol., 271, R472
Cited by
Mitochondria: More Than Just a Powerhouse
McBride, H. M., Neuspiel, M., & Wasiak, S. (2006) · Current Biology · doi:10.1016/j.cub.2006.06.054 · Cited by 1,985
Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A
Züchner, S., Mersiyanova, I. V., Muglia, M., Bissar-Tadmouri, N., Rochelle, J., Dadali, E. L., Zappia, M., Nelis, E., Patitucci, A., Senderek, J., et al. (2004) · Nature Genetics · doi:10.1038/ng1341 · Cited by 1,572
Mitochondrial Dynamics in the Regulation of Nutrient Utilization and Energy Expenditure
Liesa, M., & Shirihai, O. S. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.03.002 · Cited by 1,341
“An accompanying decrease in Mfn2 expression provided a potential mechanism to the reduction in mitochondrial size (Bach et al., 2003; Bach et al., 2005).”
BackgroundMitochondrial dynamics in health and disease: mechanisms and potential targets
Chen, W., Zhao, H., & Li, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01547-9 · Cited by 1,306
“Interestingly, deletion of hepatic MFN2 signi fi cantly promotes in fl ammatory responses, accumulation of triglycerides, fi brosis, and HCC in mouse models of NASH, whereas restoring MFN2 expression using adenovirus in mutant (liver-speci fi c) mice lacking MFN2 observably alleviate disease symptoms of NASH.”
BackgroundMitochondrial dynamics and apoptosis
Suen, D.-F., Norris, K. L., & Youle, R. J. (2008) · Genes & Development · doi:10.1101/gad.1658508 · Cited by 1,270
Metadata
- Authors
- Bach, D., Pich, S., Soriano, F. X., Vega, N., Baumgartner, B., Oriola, J., Daugaard, J. R., Lloberas, J., Camps, M., Zierath, J. R., Rabasa-Lhoret, R., Wallberg-Henriksson, H., Laville, M., Palacı́n, M., Vidal, H., Rivera, F., Brand, M., & Zorzano, A.
- Affiliations
- Parc Científic de Barcelona (ES)
- Hospital Clínic de Barcelona (ES)
- Universitat de Barcelona (ES)
- Karolinska University Hospital (SE)
- Inserm (FR)
- MRC Mitochondrial Biology Unit (GB)
- ORCID
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2003-05
- Volume
- 278
- Issue
- 19
- Pages
- 17190-17197
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2127806759
- Cited by
- 832
- References
- 50
- Citations by year
- 2026: 16 · 2025: 22 · 2024: 28 · 2023: 49 · 2022: 32 · 2021: 40 · 2020: 63 · 2019: 45 · 2018: 52 · 2017: 45 · 2016: 48 · 2015: 32 · 2014: 47 · 2013: 49 · 2012: 54
- FWCI
- 6.09
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6378 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- mitofusin 2, mitochondrial fusion, mitochondrial metabolism, myogenesis, muscle mitochondria, mitochondrial fragmentation, glucose oxidation, mitochondrial membrane potential, cellular respiration, mitochondrial proton leak, obesity, mitochondrial membrane proteins
- MeSH terms
- Animals, Gene Expression Regulation, Humans, Membrane Potentials, Membrane Proteins, Middle Aged, Mitochondria, Muscle, Obesity, Rats, Zucker, Muscle, Skeletal, GTP Phosphohydrolases, Mitochondrial Proteins, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-11-03, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-03 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Mitofusin-2 Determines Mitochondrial Network Architecture and Mitochondrial Metabolism. https://app.cochat.ai/papers/10.1074/jbc.m212754200
- The paper
- Bach, D., Pich, S., Soriano, F. X., Vega, N., Baumgartner, B., Oriola, J., Daugaard, J. R., Lloberas, J., Camps, M., Zierath, J. R., Rabasa-Lhoret, R., Wallberg-Henriksson, H., Laville, M., Palacı́n, M., Vidal, H., Rivera, F., Brand, M., & Zorzano, A. (2003). Mitofusin-2 Determines Mitochondrial Network Architecture and Mitochondrial Metabolism. Journal of Biological Chemistry. https://doi.org/10.1074/jbc.m212754200
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.